Characterisation of behavioural and neurodegenerative changes induced by intranigral 6‐hydroxydopamine lesions in a mouse model of Parkinson’s disease

Despite the widespread use of mice as models of Parkinson’s disease there is a surprising lack of validation and characterisation of unilateral lesion models in mice and the extent of behavioural impairments induced by such lesions. The aim of the present study was to characterise the behavioural deficits observed after injection of 6‐hydroxydopamine unilaterally into the substantia nigra, and correlate the behavioural impairments with the extent of damage to the mesostriatal dopaminergic pathway. We found that a recently introduced test for assessment of sensorimotor impairment, the corridor task, was particularly useful in determining lesion severity, and that this test, in combination with standard drug‐induced rotation tests, can be used to select animals with profound (≥ 80%) dopaminergic lesions that are stable over time. Based on these data we propose criteria that can be used to predict the extent of lesion, classified as severe, intermediate or mild lesions of the mesostriatal pathway. The correlation of cell loss and striatal innervation with the performance in each test provides a useful tool for the assessment of functional recovery in neurorestoration and cell transplantation studies, and for the evaluation of the in vivo efficacy and performance of stem cell‐derived dopamine neuron preparations.

[1]  M. Horne,et al.  Fetal striatum- and ventral mesencephalon–derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo , 2008, Neuroscience.

[2]  S. Dunnett,et al.  Comparison of 6-hydroxydopamine-induced medial forebrain bundle and nigrostriatal terminal lesions in a lateralised nose-poking task in rats , 2005, Behavioural Brain Research.

[3]  Joseph P Huston,et al.  Behavioral phenotyping of the MPTP mouse model of Parkinson's disease , 2001, Behavioural Brain Research.

[4]  Patrik Brundin,et al.  Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice , 2005, Behavioural Brain Research.

[5]  U. Ungerstedt,et al.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. , 1970, Brain research.

[6]  H. Lindgren,et al.  A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function , 2004, Neurobiology of Disease.

[7]  A. Björklund,et al.  Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  P. Teitelbaum,et al.  Nigrostriatal bundle damage and the lateral hypothalamic syndrome. , 1974, Journal of comparative and physiological psychology.

[9]  G. Fisone,et al.  Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia , 2005, Experimental Neurology.

[10]  A. Hartmann,et al.  Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice , 2008, Experimental Neurology.

[11]  E. Melamed,et al.  Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. , 2007, Journal of neural transmission. Supplementum.

[12]  E. Snyder,et al.  Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson's Disease , 2001, The Journal of Neuroscience.

[13]  M. Tomishima,et al.  Therapeutic cloning in individual parkinsonian mice , 2008, Nature Medicine.

[14]  O. Lindvall,et al.  Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. , 2009, Trends in pharmacological sciences.

[15]  D. Surmeier,et al.  Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. , 2008, Parkinsonism & related disorders.

[16]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[17]  Mark J. West,et al.  Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias , 1999, Trends in Neurosciences.

[18]  O. Lindvall,et al.  Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. , 2008, The Journal of clinical investigation.

[19]  K. E. Moore,et al.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants. , 1973, Neuropharmacology.

[20]  A. Björklund,et al.  Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis , 2009, Experimental Neurology.

[21]  R. Palmiter,et al.  Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity , 2005, BMC Neuroscience.

[22]  R. Schwarting,et al.  MPTP Susceptibility in the Mouse: Behavioral, Neurochemical, and Histological Analysis of Gender and Strain Differences , 2000, Behavior genetics.

[23]  S. Dunnett,et al.  Lentivector‐mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model , 2005, The European journal of neuroscience.

[24]  Anders Björklund,et al.  Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat , 1998, Experimental Neurology.

[25]  S. Dunnett,et al.  Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease , 2008, Neuroscience.

[26]  T. Schallert,et al.  Intervention Strategies for Degeneration of Dopamine Neurons in Parkinsonism , 2000 .

[27]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[28]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.

[29]  Stephen B. Dunnett,et al.  The Corridor Task: A simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum , 2005, Brain Research Bulletin.

[30]  M. Horne,et al.  The role of dopamine receptors in regulating the size of axonal arbors. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.